Stay current with the latest news on Blood Cancer United research programs, FDA approvals, research grants and awards, the Therapy Acceleration Program, Beat AML and other clinical research programs, and more.
News
TAP Biotech Partner ImCheck Therapeutics to be Acquired by Ipsen in €1B deal
Ipsen and ImCheck Therapeutics announced they have entered into a definitive agreement in which Ipsen will acquire ImCheck Therapeutics, a private Fre…
Research
BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma
LUND, SWEDEN, April 29, 2025 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and devel…
Research
BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma
Lund, Sweden – March 20, 2025 – BioInvent International AB (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of nov…
Research
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
SAN DIEGO, Feb. 05, 2025 - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from KOMET-001, the Phase 2 registra…
News
25 Patient and Provider Groups Applaud Supreme Court Ruling, Though Express Concern About Other Plaintiffs Keeping FDA Authority Challenge Alive
WASHINGTON, D.C., June 13, 2024 – Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, app…
